Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Cystatin F Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA580510
Description
This product is preservative free. It is recommended to add sodium azide to avoid contamination (final concentration 0.05%-0.1%). This antibody has specificity for Human Cystatin 7/CST7.
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the kininogens. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions. This gene encodes a glycosylated cysteine protease inhibitor with a putative role in immune regulation through inhibition of a unique target in the hematopoietic system. Expression of the protein has been observed in various human cancer cell lines established from malignant tumors.
Specifications
Cystatin F | |
Polyclonal | |
Unconjugated | |
CST7 | |
CMAP; CST7; cystatin 7; cystatin F; cystatin F (leukocystatin); cystatin-7; Cystatin-F; cystatin-like metastasis-associated protein; Leukocystatin | |
Rabbit | |
Antigen Affinity Chromatography, Protein A | |
RUO | |
8530 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with no preservative | |
O76096 | |
CST7 | |
Recombinant Human Cystatin 7/CST7 Protein (Met1-His145). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction